Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases

摘要

] agonist zolmitriptan) did not meet their endpoints in Phase II studies. Lastly, robot-assisted Repetitive Transcranial Magnetic Stimulation (rTMS) of the pre-supplementary motor area may be a promising non-pharmacological approach to alleviate dyskinesia.